Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition

Karin Von Schwarzenberg, Romina M. Wiedmann, Prajakta Oak, Sabine Schulz, Hans Zischka, Gerhard Wanner, Thomas Efferth, Dirk Trauner, Angelika M. Vollmar

Research output: Contribution to journalArticle

Abstract

The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1α (HIF1α) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1α was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1α increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1α and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.

Original languageEnglish (US)
Pages (from-to)1385-1396
Number of pages12
JournalJournal of Biological Chemistry
Volume288
Issue number2
DOIs
StatePublished - Jan 11 2013

Fingerprint

Vacuolar Proton-Translocating ATPases
Cell death
Hypoxia-Inducible Factor 1
Autophagy
Cell Death
Pharmacology
Apoptosis
Lysosomes
Chemical activation
Proton Pumps
Neoplasms
Physiological Stress
Macrolides
Tumors
Fusion reactions
Adenosine Triphosphate
Cells
Degradation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Von Schwarzenberg, K., Wiedmann, R. M., Oak, P., Schulz, S., Zischka, H., Wanner, G., ... Vollmar, A. M. (2013). Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition. Journal of Biological Chemistry, 288(2), 1385-1396. https://doi.org/10.1074/jbc.M112.412007

Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition. / Von Schwarzenberg, Karin; Wiedmann, Romina M.; Oak, Prajakta; Schulz, Sabine; Zischka, Hans; Wanner, Gerhard; Efferth, Thomas; Trauner, Dirk; Vollmar, Angelika M.

In: Journal of Biological Chemistry, Vol. 288, No. 2, 11.01.2013, p. 1385-1396.

Research output: Contribution to journalArticle

Von Schwarzenberg, K, Wiedmann, RM, Oak, P, Schulz, S, Zischka, H, Wanner, G, Efferth, T, Trauner, D & Vollmar, AM 2013, 'Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition', Journal of Biological Chemistry, vol. 288, no. 2, pp. 1385-1396. https://doi.org/10.1074/jbc.M112.412007
Von Schwarzenberg K, Wiedmann RM, Oak P, Schulz S, Zischka H, Wanner G et al. Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition. Journal of Biological Chemistry. 2013 Jan 11;288(2):1385-1396. https://doi.org/10.1074/jbc.M112.412007
Von Schwarzenberg, Karin ; Wiedmann, Romina M. ; Oak, Prajakta ; Schulz, Sabine ; Zischka, Hans ; Wanner, Gerhard ; Efferth, Thomas ; Trauner, Dirk ; Vollmar, Angelika M. / Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition. In: Journal of Biological Chemistry. 2013 ; Vol. 288, No. 2. pp. 1385-1396.
@article{489db98481c24330b0f04538fccc7993,
title = "Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition",
abstract = "The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1α (HIF1α) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1α was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1α increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1α and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.",
author = "{Von Schwarzenberg}, Karin and Wiedmann, {Romina M.} and Prajakta Oak and Sabine Schulz and Hans Zischka and Gerhard Wanner and Thomas Efferth and Dirk Trauner and Vollmar, {Angelika M.}",
year = "2013",
month = "1",
day = "11",
doi = "10.1074/jbc.M112.412007",
language = "English (US)",
volume = "288",
pages = "1385--1396",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Mode of cell death induction by pharmacological vacuolar H +-ATPase (V-ATPase) inhibition

AU - Von Schwarzenberg, Karin

AU - Wiedmann, Romina M.

AU - Oak, Prajakta

AU - Schulz, Sabine

AU - Zischka, Hans

AU - Wanner, Gerhard

AU - Efferth, Thomas

AU - Trauner, Dirk

AU - Vollmar, Angelika M.

PY - 2013/1/11

Y1 - 2013/1/11

N2 - The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1α (HIF1α) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1α was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1α increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1α and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.

AB - The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1α (HIF1α) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1α was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1α increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1α and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.

UR - http://www.scopus.com/inward/record.url?scp=84872288221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872288221&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.412007

DO - 10.1074/jbc.M112.412007

M3 - Article

VL - 288

SP - 1385

EP - 1396

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -